Viral and Host Factors in the Transmission and Pathogenesis of HIV
NCT00219947 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 600
Last updated 2019-04-10
Summary
To study the collection of blood from individuals known to be at high risk for HIV-infection or who have been recently infected with HIV.
The data collected are used for diagnostic, prognostic and management decisions as outlined by current HIV-1 Treatment Guidelines.
Conditions
- HIV Infections
Interventions
- OTHER
-
blood draw
* T cell subset enumeration * Serologic reactivity with HIV antigens * Viral load assays by bDNA, PCR, or RT-PCR * Routine Laboratory assessments (chemistries, liver function tests, hepatitis serology, RPR) * HIV-1 Resistance Testing
Sponsors & Collaborators
-
Rockefeller University
lead OTHER
Principal Investigators
-
Martin M Markowitz, MD · Rockefeller University
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-07-31
- Primary Completion
- 2019-03-31
- Completion
- 2019-03-31
Countries
- United States
Study Locations
More Related Trials
-
HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy
NCT00709397 ·Status: TERMINATED
-
Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD
NCT04311944 ·Status: UNKNOWN ·Phase: NA
-
A Pilot Study to Determine if Raltegravir Eradicates HIV From Peripheral Blood Mononuclear Cells
NCT01173510 ·Status: WITHDRAWN ·Phase: PHASE4
-
Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients
NCT02934022 ·Status: COMPLETED ·Phase: NA
-
Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy
NCT02611895 ·Status: COMPLETED ·Phase: NA
-
Treatment of Acute HIV Infection With Quad Fixed-dose Combination (FDC) Tablet
NCT01694420 ·Status: COMPLETED ·Phase: PHASE3
-
Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)
NCT01814722 ·Status: TERMINATED
-
The Use of Leukapheresis to Support HIV Pathogenesis Studies
NCT01161199 ·Status: RECRUITING
-
Standard Antiretroviral v. Multi-class Therapy in Acutely HIV-1 Infected Antiretroviral-Naïve Subjects (ADARC 2007-01)
NCT00525733 ·Status: COMPLETED ·Phase: NA
-
Development of a New Family of HIV Latency Regulators (LRAs) Targeting the Tat Viral Protein
NCT06441123 ·Status: RECRUITING
-
A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1
NCT00100984 ·Status: TERMINATED ·Phase: PHASE4
-
Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia
NCT00618371 ·Status: COMPLETED ·Phase: NA
-
Immune and Viral Status of HIV-Infected Patients After Stopping Combination Antiretroviral Therapy
NCT00001899 ·Status: COMPLETED
-
Administration of High Doses of Antiretroviral Drugs to Eliminate the Latent HIV-1 Reservoir
NCT06640192 ·Status: RECRUITING ·Phase: PHASE2
-
Immune Reconstitution of Lopinavir/Ritonavir-Based vs Efavirenz-based HAART in Advanced HIV Disease
NCT00775606 ·Status: TERMINATED ·Phase: PHASE4
-
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
NCT00855413 ·Status: TERMINATED ·Phase: PHASE4
-
Intermittent Versus Continuous Medication in the Treatment of HIV
NCT00001967 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment Intensification for HIV Infected Patients With Multi-Drug Resistant Virus
NCT00102934 ·Status: UNKNOWN ·Phase: NA
-
An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART
NCT01541085 ·Status: COMPLETED
-
Raltegravir Therapy for Women With HIV and Fat Accumulation
NCT00656175 ·Status: COMPLETED ·Phase: PHASE2
-
Assess the Downregulation of HIV-1 When Raltegravir is Added to a Virologically Suppressed HAART Regimen
NCT00738569 ·Status: COMPLETED ·Phase: NA
-
VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption
NCT02471326 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of HAART Vs. Statin Treatment on Endothelial Function and Inflammation/Coagulation
NCT01515813 ·Status: WITHDRAWN ·Phase: PHASE2
-
Evaluation of Innovative Combinatorial stratégies of Anti-latency and Anti-immune Activation Drugs Targeting HIV Reservoir
NCT04741100 ·Status: WITHDRAWN
-
Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients
NCT00128908 ·Status: TERMINATED ·Phase: PHASE4